SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Summit Therapeutics Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors


Werte in diesem Artikel

NEW YORK, July 10, 2023 /PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Summit Therapeutics Inc. (NASDAQ: SMMT).

If you are a shareholder of Summit Therapeutics Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at:

https://pjlfirm.com/summit-therapeutics-inc/

You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000.  One of our attorneys will personally speak with you about the case at no cost or obligation.

Purcell & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit https://pjlfirm.com.   Attorney advertising. Prior results do not guarantee a similar outcome. 

Cision View original content:https://www.prnewswire.com/news-releases/shareholder-alert-purcell--lefkowitz-llp-is-investigating-summit-therapeutics-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors-301872821.html

SOURCE Purcell & Lefkowitz LLP

Aktuelle Summit Therapeutics Aktie News

Werbung

Summit Therapeutics Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Summit Therapeutics nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"

Keine Analysen gefunden.